Welcome to the website of DSM Sinochem Pharmaceuticals!

We are DSM Sinochem Pharmaceuticals. A global leader in environmentally friendly anti-infective molecules, DSM Sinochem Pharmaceuticals is at the forefront of technological and process developments for antibiotics. We are here to make a difference – keeping our customers ahead of the competition with top quality products and services and the highest standards of sustainability, quality and reliability.

DSM Sinochem Pharmaceuticals today announced that it has completed construction of a world-class statins plant  in Toansa, India. Production of atorvastatin started  in the second half of 2014, using DSP’s proprietary enzymatic (bio)technology route. The new plant is included in the updated CEP (CEP 2010-366, revision 2) for Atorvastatin Calcium from DSP. Readmore

President Karl Rotthier speaks with the UK's Daily Telegraph.

Drug companies’ poor practices are to blame for the rise of antibiotic resistance which threatens to make even the smallest infections deadly, one industry chief executive has claimed. Doctors have usually been blamed for bacterial resistance because of overprescription, but Karl Rotthier, the chief executive of Dutch-based DSM Sinochem Pharmaceuticals, claims lax procedures at drugs firms are the real cause. He said the very industry that produced lifesaving antibiotics was fuelling a global crisis. Readmore

DSP publishes Sustainability Report 2014.


DSM Sinochem Pharmaceuticals (DSP) issues the 2014 Sustainability Report, inspired by the GRI framework. The Report gives an overview of DSP's business and sustainability performance and DSP's efforts on Sustainable Antibiotics. 

Karl Rotthier, CEO of DSP, highlighted the importance of antibiotics for mankind and our responsibility to ensure that these life-saving drugs remain effective and are thus produced responsibly.Readmore